OR WAIT null SECS
The company's Advanced Lipids line is the subject of several upcoming scientific articles.
Enzymotec (Kfar Baruch, Israel) says research is ramping up on Advanced Lipids, the company’s line of lipid-based ingredients for infant nutrition. The company expects four scientific articles on its ingredients to be published in the coming months.
Advanced Lipids is a joint venture between Enzymotec and AAK, featuring ingredients intended to mimic the lipids found in mother’s milk. One of those ingredients is InFat: a beta-palmitate ingredient that Enzymotec says mimics the properties of human milk fat, allowing for easy digestion and uptake of calcium, fat recovery, and energy.
“The clinical trials plan represents Enzymotec’s ongoing commitment to explore the special characteristics of human milk and demonstrate its lipid-based ingredients’ health benefits on various infant populations,” says Yael Lifshitz, PhD, director of R&D for Enzymotec Infant Nutrition. “We developed this innovative ingredient and educated the premium infant formula market over the last several years. Enzymotec invested 10% of its revenue in research and development-a percentage considered among the highest in the industry.”